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Using microCT (Skyscan, Belgium), trabecular bone volume fraction
(BV/TV), trabecular thickness (TbTh) and subchondral plate thickness
(PlTh) were calculated for the epiphyseal part of the tibias. Next, the
tibias were sectioned for histological analysis. The osteoarthritis cartilage
histopathology scoring was used to evaluate the cartilage damage in
medial and lateral compartment of the tibial epiphysis. For each compart-
ment, a maximum score of 24 can be reached. In addition, the presence
or absence of osteophytes was scored.
Results: Cartilage and osteophytes: Overall, the cartilage damage
scores were fairly low, up to a score of 4. In −/−, ERbeta−/−, and
ERalpha−/−ERbeta−/− mice, there was no difference in cartilage damage
score when compared to wt mice.
In the ERalpha−/−ERbeta−/− mice, more and/or larger (seen in more
histological sections) osteophytes were present compared with wt mice.
Subchondral plate thickness: In the ERalpha−/− and ERbeta−/− mice, no
difference in subchondral plate thickness was observed when compared
with wt mice. In the ERalpha−/−ERbeta−/− mice, the subchondral plate
was thinner than in the wt mice, but only at the lateral side.
Epiphysis: In the WT and ERalpha−/− mice, no signiﬁcant differences
were observed in trabecular BV/TV and TbTh. In contrast, in the
ERbeta−/− mice, trabecular BV/TV was 13% higher than in the wt, but
there was no difference in TbTh. In the ERalpha−/−ERbeta−/− mice,
trabecular BV/TV and TbTh were 11% lower than in the WT mice.
Conclusions: No cartilage changes were found in the ERalpha,
ERbeta−/−, ERalpha−/−ERbeta−/− mice at 6 months of age. In the single
knockout mice, deletion of one of the estrogen receptors may be compen-
sated by the other estrogen receptor. However, in the double knockout
mice, this is not the case. Increased cartilage damage was expected
in the double knockout mice, as osteoarthritic cartilage changes were
found in both rats and monkeys when estrogen signaling was inhibited by
ovariectomy. The differences in epiphyseal trabecular bone phenotype did
not inﬂuence the cartilage damage in the knockout mice. We did see more
or larger osteophytes in the double knockout mice, indicating that there
are some osteoarthritic developments. In the double knockout the lateral
subchondral plate thickness was decreased, which is also observed in
several osteoarthritic animal models. The increased osteophytosis and
changed subchondral plate is an indication that at later age these mice
likely develop more osteoarthritic changes.
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Purpose: We assessed the capacity of PRGF to impact OA progres-
sion in sheep following trauma to the joint caused by ACL rejection
and cartilage defects performed on the medial condyle. This objective
was ﬁrst addressed by studying macroscopic cartilage changes in the
femoropatellar and femorotibial compartments.
Methods: Latxa sheep ranging in age from 3 to 8 years (5.0±1.9 years)
and weighing 62±9 kg (range: 47.8−74.4 kg) were used. A body condition
score was evaluated by a senior veterinarian by estimating the level of
muscling and fat [Editor1]deposition over and around the vertebrae in
the loin region (scored from 1 to 5). The Neiker-Technalia Animal Care
and Use Committee approved all procedures used. TGF-b levels were
assessed in PRGF and synovial ﬂuids by ELISA.
Sheep operations were performed bilaterally. Spinal anaesthesia was
induced in the hind limbs with bupivacaine. A medial parapatellar incision
was made and the patella was reﬂected laterally in order to expose the
ACL, which was subsequently transected. Complete thickness cartilage
defects were performed in the medial femoral condyles of both knees.
Following the surgery, free movement was allowed.
Ultrasound-guided inﬁltrations were initiated three weeks after ACL tran-
section. Sheep were treated with a series of six biweekly intra-articular
injections of 4ml of PRGF preparation and 4ml of saline in the contralat-
eral knee. PRGF and saline treatments were randomized to either the
right or the left knee.
OA induction was followed-up by radiography. Sheep were sacriﬁced
when OA features were evident on radiological images. This occurred at
36−38 weeks post-surgery, 16−18 weeks after the end of the treatment.
Knees were macroscopically studied for the presence of osteophytes
and signs of cartilage degeneration. Lateral and medial femur condyles,
tibial plateaux, and retropatellar cartilage were inspected. The articular
surfaces of the patella and tibial plateau were stained with diluted India
ink (1:5 v/v) to enhance detection of ﬁbrillation. Specimens were pho-
tographed, and images were assessed using a digital program. The ﬁbril-
lation area relative to the total area was calculated. ANOVA analysis was
performed to assess the inﬂuence of treatment modality on macroscopic
assessments. Age and body condition score were used as covariables.
Results: Body condition scoring ranged from 2.25 to 3.0 (2.73±0.27).
Most sheep (n = 9) were able to stand up 1−3 hours after surgery. PRGF
is a plasma preparation containing a moderate number of platelets,
448×106±194×106 platelets/cc, platelet volume was 4.8±0.3 ftl. The
levels of TGF-b1 in the PRGF were 13,240±5,650 ng/ml as assessed
by ELISA. Platelet number correlated signiﬁcantly with TGF-b1, Pearson
correlation = 0.9079, p< 0.001. Intra-articular TGF-b at the time of sacri-
ﬁce was 1983 pg/ml (CI: 1561–2406) in the treated joint and 1513 pg/ml
(CI: 1127–1898) in the saline group, p = 0.1015. Body condition score,
but not age, signiﬁcantly inﬂuenced the intra-articular levels of TGF-b1,
p = 0.0306. Transection of the ACL and full thickness defects in the medial
condyle resulted in the development of lesions in the lateral femoral
condyle, meniscus, tibial plateau, and patella. Osteophytes were located
mainly on the patellar trochlea ridge. Changes in the tibial plateau are
shown in Table 1. The percentage of patella ﬁbrillation was 10.1% (CI:
5.95%-14.24%) for the saline group and 4.3% (0.17%-8. 46%) for the
PRGF group, p = 0.053. Age signiﬁcantly inﬂuenced patella ﬁbrillation,
p = 0.036.
Conclusions: This study suggests that there may be a therapeutic beneﬁt
associated with intra-articular injection of PRGF following traumatic injury
to the knee.
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Purpose: A standardised powder prepared from rose-hip (Rosa canina),
has shown anti-inﬂammatory properties and improved the ﬂexibility of
the hip and knee joints and reduced pain in humans suffering from the
early as well as the late stages of osteoarthritis. Recently a galactolipid
named GOPO with anti-inﬂammatory properties was isolated from this
rose-hip powder. The present study aimed to investigate if LitoVet, a rose-
hip powder produced by HybenVital, especially for animals, would affect
the immune system, working capacity and behaviour of horses exposed
to strenuous exercise.
Methods: Seventy-four horses, all trotters, which often develop os-
teoarthritis early in their life, due to their intensive training program and
their performance in an oval track, were included in a double blind,
placebo controlled trial. The horses were randomized in blocks of three
of which two were given LitoVet (210 g daily as a dry powder added to
their food) and one was given the same amount of placebo powder with a
similar taste, odour and colour. Both groups of horses were then treated
for a three months period. The anti-inﬂammatory capacity was estimated
as chemotaxis of peripheral blood neutrophils using a Boyden chamber,
the anti-oxidative capacity by using chemiluminescence and by simply
measuring the vitamin C content of serum. The working capacity of the
horses was estimated by counting the seconds used to run 1000 meter
and the behaviour of the horses was evaluated on questionnaires which
was answered by the staff daily taking care of the horses (data given are
mean±sd).
Results: During LitoVet treatment neutrophil chemotaxis declined from
30.4±14.0 to 9.0±13.5 indicating an enhanced anti-inﬂammatory activity
(p< 0.004). No change was observed during placebo. LitoVet also signif-
icantly improved the antioxidant capacity when estimated as chemilumi-
nescence (p< 0.05) and the vitamin C content or serum (p< 0.05). Horses
on LitoVet also shortened their time to run 1000 meter as shown by a
mean decline of 1.1±1.5 second (p< 0.02). The placebo group slightly
increased their time to run the same distance. In agreement with the
changes described above it was reported from questionnaires, that the
horses beneﬁt from LitoVet treatment (p< 0.05) and that horses on LitoVet
were more lithe after strenuous exercise than horses treated with placebo
(p< 0.05).
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Conclusions: The present data suggest that LitoVet has anti-
inﬂammatory properties in horses. This can possibly explain why the
horses were able to improve their speed running 1000 meter and why
they were more lithe after strenuous exercise.
70 INFLUENCE OF RISEDRONATE TO BONE AND CARTILAGE
METABOLISM MARKERS IN AN OVARIECTOMIZED RAT
H. Ichinose. Fujita Helth University, Toyoake, JAPAN
Purpose: It has been reported that cartilage metabolism markers are
inﬂuenced by clinical administration of risedronate. We used the ovariec-
tomized (OVX) model rat which is a postmenopausal osteoporosis model
in this study and evaluated the inﬂuence of risedronate administration on
bone and cartilage metabolism markers.
Methods: Ovariectomy was performed to SD rats (total 34 rats, about
6 months after birth). 0.1, 1.0 and 2.5mg/kg/day of risedronate was
orally administrated every day immediately after the operation for 8th
weeks. Urinary D-Pyr, CTX-II and Serum CTX-I levels were determined
atpre-operation, middle and end of administration. Serum COMP levels
weredetermined at the end of risedronate administration.
Results: Serum COMP levels slightly increased in OVX group and
decreased dose-dependently in risedronate administrated group. CTX-
II levels showed the same changes as COMP, however the effect of
risedronate decreased in 8th week. Levels of D-Pyr, CTX-II and CTX-I
increased in OVX group compared inSham group and decreased dose-
dependently in risedronate administrated group. Signiﬁcant positive rela-
tions were observed between D-Pyr/CTX-I and CTX-II/COMP at 4th and
8th weeks.
Conclusions: Cartilage metabolic turnover was enhanced by OVX and
this enhancement was reversed by risedronate. Above data suggested
that risedronate administration to OVX rat resulted in signiﬁcant changes
of both type I and II collagen metabolism.
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NON-INVASIVE INDUCTION OF LESIONS?
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Purpose: Articular cartilage is essential for friction-free joint movement.
Loss of articular cartilage integrity in osteoarthritis (OA) is a major cause
of disability. Despite this, the factors inﬂuencing initiation and progression
of OA remain poorly deﬁned, partly due to a lack of appropriate animal
models. Clinical experience and epidemiological studies indicate that
joint loading promotes cartilage degeneration. Our development of a
non-surgical model of mouse tibial loading through natural articulation
points, offers unique opportunities to address whether well-deﬁned and
controlled joint loading induces development of OA-like lesions. Our
studies will address the hypothesis that in vivo loading induces the
formation of localised lesions in the articular cartilage of mouse knee
joints.
Methods: In vivo loading: right knees of 22 week-old male ‘OA-prone’
Str/ort mice, ‘OA-protected’ CBA mice and mice with intermediate OA
susceptibility C57BL/6, were cyclically loaded as described by De Souza
et al (2005), 3 times/week for 2 (C57BL/6 and CBA) or 4 weeks (Str/ort),
at a magnitude of 9N, 0.1Hz frequency with 40 cycles each day. The
animals were killed 2 days after the ﬁnal loading episode.
Histology : Serial 9mm sections of the entire wax embedded knee were
cut and one third of the slides stained with Toluidine blue and graded as
described below.
Grading and statistics: Grading of lesion severity was achieved by the
methods of Chambers et al (2002). Lesions were scored from 0 (normal
cartilage) to 6 (loss of more than 80% of the articular cartilage). Each joint
compartment (medial/lateral and tibia/femur) was graded separately and
a grade for the whole joint also recorded. Loaded knees were compared
to the contra-lateral non-loaded knees using a paired ttest. Data were
shown as mean±SEM.
Results: Our results show that knee joints of all three strains of mice
exhibit increases in the severity of overt lesions in response to applied
loads; with loaded knees showing statistically signiﬁcant increases in
both mean and maximum OA-grades in C57BL/6 and CBA mice, and
signiﬁcant increases only in the mean OA-grade in Str/ort mice.
Load-induced increases in lesion severity were most marked in the lateral
femur, but failed to reach levels of signiﬁcance in other compartments
of C57BL/6 and CBA mice. In Str/ort mice, load-induced lesions were
signiﬁcant in the medial and lateral femoral compartments, but tibial
compartments, in which OA lesions develop spontaneously, were not
signiﬁcantly affected by loading.
Conclusions: In vivo murine knee joint loading can induce articular
cartilage lesions in three mouse strains. The load-induced lesions were
similar in mice which exhibit divergent susceptibility to spontaneous OA,
namely the OA-prone Str/ort mice, the OA-resistant CBA mice, and
C57BL/6 mice which exhibit a ‘normal’, intermediate incidence of OA.
In addition, the location of load-induced lesions was consistently in the
femoral compartment. As this differs from the predominant location of
naturally-occurring lesions on the tibia of Str/ort mice, it establishes scope
for comparing the progression of natural OA lesions and load-induced
lesions within the same joint. Our data also provide the basis for future
studies aimed at reﬁning applied loads to develop a novel model for OA
induction. Indeed, this model provides many advantages, including: non-
surgical controlled induction of OA, availability of contra-lateral control
joints, scope for longitudinal studies in an appropriate species that will
allow us to deﬁne the most osteoarthritogenic loads, as well as the role
of speciﬁc genes in OA using genetic mutant mice.
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Purpose: Experimental and clinical investigations indicated a positive
effect of collagen hydrolysate in the treatment of osteoarthritis. More
recently, it could be demonstrated that orally administered collagen hy-
drolysate was able to halt cartilage degeneration in mice suffering from
osteoarthritis (OA).
The objective of this study was to evaluate the prophylactic efﬁcacy of a
special orally administered collagen hydrolysate on the development and
progression of OA in an appropriate animal model.
Methods: The efﬁcacy of collagen hydrolysate was tested in a ran-
domly assigned placebo-controlled animal study on male STR mice.
The STR/ort mouse strain develops a naturally occurring OA at a high
incidence in the medial tibial plateau of the knee, resembling human
osteoarthritis. In 2 month old STR/ort mice 0.15mg/g body weight of
a special collagen hydrolysate (FORTIGEL, GELITA AG) was orally
administered once daily over a treatment period of 4 months. Animals
in the placebo group received albumin (BSA) in the same dosage. At the
end of the study, thin tissue sections of the knee cartilage were analyzed
for osteoarthritic changes. The stained samples were evaluated by two
blinded pathologists independently. OA joint damage was assessed by
a well-deﬁned semi-quantitative histopathological score for both cohort
groups.
Results: In the non-treated STR/ort mice progression of the determined
grade of OA correlated with the aging of the animals. At the beginning
of the study no appreciable osteoarthritic changes could be revealed in
the knee joints of the 2 month old mice, whereas more than 80% of the
animals under investigation developed OA-like lesions at the end of the
study.
The prophylactic treatment with orally administered FORTIGEL over
4 months led to a pronounced decrease in cartilage tissue degeneration
in the knee joints. The incidence of severe joint destruction was clearly
reduced after FORTIGEL treatment and the determined grade of OA
decreased signiﬁcantly (p< 0.05) in comparison to the untreated control
animals.
Moreover, the data suggested a correlation between the determined
grade of OA and the body weight of the STR/ort mice.
Conclusions: The results indicate that prophylactic treatment with orally
administered FORTIGEL decreases cartilage degeneration in STR/ort
mice and seems to retard the progression of OA. The data obtained
from this study suggest that collagen hydrolysate could be of potential
interest as a disease-modifying agent for the prevention of degenerative
joint diseases.
